Literature DB >> 22692671

Structure-activity relationship for hydrophobic salts as viscosity-lowering excipients for concentrated solutions of monoclonal antibodies.

Zheng Guo1, Alvin Chen, Roger A Nassar, Bernhard Helk, Claudia Mueller, Yu Tang, Kapil Gupta, Alexander M Klibanov.   

Abstract

PURPOSE: To discover, elucidate the structure-activity relationship (SAR), and explore the mechanism of action of excipients able to drastically lower the viscosities of concentrated aqueous solutions of humanized monoclonal antibodies (MAbs).
METHODS: Salts prepared from hydrophobic cations and anions were dissolved into humanized MAbs solutions. Viscosities of the resulting solutions were measured as a function of the nature and concentration of the salts and MAbs.
RESULTS: Even at moderate concentrations, some of the salts prepared herein were found to reduce over 10-fold the viscosities of concentrated aqueous solutions of several MAbs at room temperature.
CONCLUSIONS: To be potent viscosity-lowering excipients, the ionic constituents of the salts must be hydrophobic, bulky, and aliphatic. A mechanistic hypothesis explaining the observed salt effects on MAb solutions' viscosities was proposed and verified.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22692671     DOI: 10.1007/s11095-012-0802-9

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

Review 1.  Challenges in the development of high protein concentration formulations.

Authors:  Steven J Shire; Zahra Shahrokh; Jun Liu
Journal:  J Pharm Sci       Date:  2004-06       Impact factor: 3.534

2.  Factors affecting the viscosity in high concentration solutions of different monoclonal antibodies.

Authors:  Sandeep Yadav; Steven J Shire; Devendra S Kalonia
Journal:  J Pharm Sci       Date:  2010-12       Impact factor: 3.534

3.  Rheological and syringeability properties of highly concentrated human polyclonal immunoglobulin solutions.

Authors:  V Burckbuchler; G Mekhloufi; A Paillard Giteau; J L Grossiord; S Huille; F Agnely
Journal:  Eur J Pharm Biopharm       Date:  2010-08-16       Impact factor: 5.571

Review 4.  Protein drug stability: a formulation challenge.

Authors:  Sven Frokjaer; Daniel E Otzen
Journal:  Nat Rev Drug Discov       Date:  2005-04       Impact factor: 84.694

5.  Reversible self-association increases the viscosity of a concentrated monoclonal antibody in aqueous solution.

Authors:  Jun Liu; Mary D H Nguyen; James D Andya; Steven J Shire
Journal:  J Pharm Sci       Date:  2005-09       Impact factor: 3.534

6.  Hydrophobic salts markedly diminish viscosity of concentrated protein solutions.

Authors:  Wei Du; Alexander M Klibanov
Journal:  Biotechnol Bioeng       Date:  2010-11-17       Impact factor: 4.530

7.  Polysorbate 20 prevents the precipitation of a monoclonal antibody during shear.

Authors:  Thomas W Patapoff; Osigwe Esue
Journal:  Pharm Dev Technol       Date:  2009       Impact factor: 3.133

8.  Reversible self-association of a human myeloma protein. Thermodynamics and relevance to viscosity effects and solubility.

Authors:  C G Hall; G N Abraham
Journal:  Biochemistry       Date:  1984-10-23       Impact factor: 3.162

Review 9.  Milk proteins: physicochemical and functional properties.

Authors:  J E Kinsella
Journal:  Crit Rev Food Sci Nutr       Date:  1984       Impact factor: 11.176

10.  Crystalline monoclonal antibodies for subcutaneous delivery.

Authors:  Mark X Yang; Bhami Shenoy; Matthew Disttler; Reena Patel; Margaret McGrath; Sergey Pechenov; Alexey L Margolin
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-02       Impact factor: 11.205

View more
  11 in total

1.  Viscosity Analysis of Dual Variable Domain Immunoglobulin Protein Solutions: Role of Size, Electroviscous Effect and Protein-Protein Interactions.

Authors:  Ashlesha S Raut; Devendra S Kalonia
Journal:  Pharm Res       Date:  2015-08-19       Impact factor: 4.200

Review 2.  Molecular basis of high viscosity in concentrated antibody solutions: Strategies for high concentration drug product development.

Authors:  Dheeraj S Tomar; Sandeep Kumar; Satish K Singh; Sumit Goswami; Li Li
Journal:  MAbs       Date:  2016-01-06       Impact factor: 5.857

Review 3.  Advanced protein formulations.

Authors:  Wei Wang
Journal:  Protein Sci       Date:  2015-05-01       Impact factor: 6.725

4.  Rational design of viscosity reducing mutants of a monoclonal antibody: hydrophobic versus electrostatic inter-molecular interactions.

Authors:  Pilarin Nichols; Li Li; Sandeep Kumar; Patrick M Buck; Satish K Singh; Sumit Goswami; Bryan Balthazor; Tami R Conley; David Sek; Martin J Allen
Journal:  MAbs       Date:  2015       Impact factor: 5.857

Review 5.  Structure, heterogeneity and developability assessment of therapeutic antibodies.

Authors:  Yingda Xu; Dongdong Wang; Bruce Mason; Tony Rossomando; Ning Li; Dingjiang Liu; Jason K Cheung; Wei Xu; Smita Raghava; Amit Katiyar; Christine Nowak; Tao Xiang; Diane D Dong; Joanne Sun; Alain Beck; Hongcheng Liu
Journal:  MAbs       Date:  2018-12-17       Impact factor: 5.857

6.  Contrasting the Influence of Cationic Amino Acids on the Viscosity and Stability of a Highly Concentrated Monoclonal Antibody.

Authors:  Barton J Dear; Jessica J Hung; Thomas M Truskett; Keith P Johnston
Journal:  Pharm Res       Date:  2016-11-11       Impact factor: 4.200

7.  Non-aqueous suspensions of antibodies are much less viscous than equally concentrated aqueous solutions.

Authors:  Charudharshini Srinivasan; Alisha K Weight; Till Bussemer; Alexander M Klibanov
Journal:  Pharm Res       Date:  2013-03-30       Impact factor: 4.200

8.  Concentration dependent viscosity of monoclonal antibody solutions: explaining experimental behavior in terms of molecular properties.

Authors:  Li Li; Sandeep Kumar; Patrick M Buck; Christopher Burns; Janelle Lavoie; Satish K Singh; Nicholas W Warne; Pilarin Nichols; Nicholas Luksha; Davin Boardman
Journal:  Pharm Res       Date:  2014-06-07       Impact factor: 4.200

Review 9.  Viscosity Control of Protein Solution by Small Solutes: A Review.

Authors:  Taehun Hong; Kazuki Iwashita; Kentaro Shiraki
Journal:  Curr Protein Pept Sci       Date:  2018       Impact factor: 3.272

10.  Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies.

Authors:  Subhabrata Majumder; Deep S Bhattacharya; Alex Langford; Arun Alphonse Ignatius
Journal:  Pharm Res       Date:  2022-02-16       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.